95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.28%
Negative revenue growth while RGLD stands at 11.48%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-17.67%
Negative gross profit growth while RGLD is at 17.37%. Joel Greenblatt would examine cost competitiveness or demand decline.
-6.08%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-6.08%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
30.00%
Net income growth above 1.5x RGLD's 12.62%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
75.00%
EPS growth above 1.5x RGLD's 3.27%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
75.00%
Positive diluted EPS growth while RGLD is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.40%
Share reduction more than 1.5x RGLD's 11.50%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.45%
Diluted share reduction more than 1.5x RGLD's 11.36%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
5.22%
OCF growth under 50% of RGLD's 62.80%. Michael Burry might suspect questionable revenue recognition or rising costs.
5.22%
FCF growth under 50% of RGLD's 54.57%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
210.94%
10Y revenue/share CAGR under 50% of RGLD's 851.10%. Michael Burry would suspect a lasting competitive disadvantage.
149.23%
5Y revenue/share CAGR similar to RGLD's 155.13%. Walter Schloss might see both companies benefiting from the same mid-term trends.
51.45%
3Y revenue/share CAGR at 50-75% of RGLD's 89.46%. Martin Whitman would question if the firm lags behind competitor innovations.
1261.50%
10Y OCF/share CAGR in line with RGLD's 1309.61%. Walter Schloss would see both as similarly efficient over the decade.
330.54%
5Y OCF/share CAGR above 1.5x RGLD's 88.38%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
67.97%
3Y OCF/share CAGR above 1.5x RGLD's 34.89%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
426.93%
5Y net income/share CAGR above 1.5x RGLD's 48.67%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
133.14%
3Y net income/share CAGR above 1.5x RGLD's 11.62%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
1497.53%
10Y equity/share CAGR at 50-75% of RGLD's 2728.93%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
453.49%
5Y equity/share CAGR above 1.5x RGLD's 265.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
68.14%
3Y equity/share CAGR at 50-75% of RGLD's 123.56%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.44%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-0.67%
Negative asset growth while RGLD invests at 0.08%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
6.55%
Positive BV/share change while RGLD is negative. John Neff sees a clear edge over a competitor losing equity.
-5.88%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-19.14%
We cut SG&A while RGLD invests at 26.63%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.